Sanchez-Lopez D, Garcia-Vega D, Vinuela JE, Ferreiros-Vidal I, et al. FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide. J Mol Cell Cardiol 2025 Nov 1:S0022-2828(25)00193.
PMID: 41183609